Atopic Dermatitis study: Dupixent
Official title Dupixent and Narrowband UVB for Atopic Dermatitis
ClinicalTrials.gov ID: NCT05285839
What this study is testing
What is Dupixent?
An investigational once‑weekly injectable medicine being studied for atopic dermatitis. Dupilumab is designed to block IL‑4 and IL‑13 signaling in the body.
Also referred to as dupilumab.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to learn how safe and effective the combination of dupilumab and narrowband UVB is, and whether dupilumab alone works after the combination period.
- Who it's for
- People who have atopic dermatitis.
- What's involved
- You will receive dupilumab injections and narrowband UVB light treatments three times a week for 12 weeks, then continue dupilumab alone for another 12 weeks, with regular check‑ups and tests.
- Time commitment
- The trial lasts about 24 weeks and includes multiple clinic visits for treatment and monitoring.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female adult ≥ 18 years of age;
- EASI score of 16 or greater,
- IGA score of 3 or greater
- BSA of 10% or greater,
You likely can't join if
- people with previous exposure to dupilumab.
- Known or suspected hypersensitivity to dupilumab or any of its excipients.
- History of photosensitivity.
The study team makes the final eligibility decision.
Where it is enrolling
- East Windsor, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at East Windsor, New Jersey, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.